Amdocs is a software - infrastructure business based in the US. Amdocs shares (DOX) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $88.32 – an increase of 0.38% over the previous week. Amdocs employs 29,058 staff and has a trailing 12-month revenue of around $4.9 billion.
Offer ends 4/1/25. Customer must fund their Active invest account with at least $50 within 30 days of opening the account. Probability of customer receiving $2,000 is 0.028%. See full terms and conditions at https://www.sofi.com/greenintwoterms/.
Open an account.Provide your personal information and sign up.
Fund your account.Deposit funds into your account by linking your banking information or transfer funds from another trading account.
Search for the stock name – DOX.Search for the stock by name or ticker symbol.
Buy the stock. Place your order. It's that simple.
Buy Amdocs stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 4 of 4
What is the Finder Score?
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Amdocs stock price (NASDAQ: DOX)
Use our graph to track the performance of DOX stocks over time.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Amdocs price performance over time
Historical closes compared with the close of $88.32 from 2025-03-20
1 week (2025-03-14)
0.38%
1 month (2025-02-21)
0.36%
3 months (2024-12-20)
1.51%
6 months (2024-09-20)
2.45%
1 year (2024-03-22)
-2.19%
2 years (2023-03-22)
-0.75%
3 years (2022-03-22)
15.75%
5 years (2020-03-20)
110.41%
Is Amdocs stock undervalued or overvalued?
Valuing Amdocs stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Amdocs's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Amdocs's P/E ratio
Amdocs's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 20x. In other words, Amdocs shares trade at around 20x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Amdocs's PEG ratio
Amdocs's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.1347. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Amdocs's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Amdocs's EBITDA
Amdocs's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $974.6 million.
The EBITDA is a measure of a Amdocs's overall financial performance and is widely used to measure a its profitability.
Amdocs financials
Revenue TTM
$4.9 billion
Operating margin TTM
18.52%
Gross profit TTM
$1.8 billion
Return on assets TTM
7.65%
Return on equity TTM
14.05%
Profit margin
10.19%
Book value
$30.89
Market Capitalization
$9.9 billion
TTM: trailing 12 months
Amdocs share dividends
Dividend payout ratio: 30.03% of net profits
Recently Amdocs has paid out, on average, around 0% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Amdocs shareholders could enjoy a 0% return on their shares, in the form of dividend payments. In Amdocs's case, that would currently equate to about $1.916 per share.
While Amdocs's payout ratio might seem fairly standard, it's worth remembering that Amdocs may be investing much of the rest of its net profits in future growth.
Amdocs's most recent dividend payout was on 24 April 2025. The latest dividend was paid out to all shareholders who bought their shares by 30 March 2025 (the "ex-dividend date").
Amdocs share price volatility
Over the last 12 months, Amdocs's shares have ranged in value from as little as $73.1387 up to $92.8158. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Amdocs's is 0.693. This would suggest that Amdocs's shares are less volatile than average (for this exchange).
Amdocs overview
Amdocs Limited, through its subsidiaries, provides software and services to communications, entertainment, and media service providers worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES24, a set of embedded GenAI-driven assistants powered by the amAIz platform designed to empower service providers to transform their business; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; Amdocs connectX, a cloud-native telco-in-a-box software-as-a-service platform designed for digital telecom brands; and Amdocs eSIM Cloud enables service providers. It also offers consulting, experience design, data, cloud, network services, delivery, quality engineering, operations, systems integration, and content services to various platforms and technologies; maintenance, enhancement design and development, and operational support services; network deployment and optimization services; and managed services, including AI and related tools, predictive analytics, and robotic process automation. In addition, the company provides quality engineering, mobile network, data intelligence, cloud, and professional services. Amdocs Limited was founded in 1982 and is headquartered in Saint Louis, Missouri. .
Frequently asked questions
null What percentage of Amdocs is owned by institutions? Currently 100.908% of Amdocs shares are held by institutions.How many people work for Amdocs? Latest data suggests 29,058 work at Amdocs.When does the fiscal year end for Amdocs? Amdocs's fiscal year ends in September.Where is Amdocs based? Amdocs's address is: 625 Maryville Centre Drive, Saint Louis, MO, United States, 63141What is Amdocs's ISIN number? Amdocs's international securities identification number is: USG026021034What is Amdocs's CUSIP number? Amdocs's Committee on Uniform Securities Identification Procedures number is: G02602103
A deep dive into the highlights and limitations of Robinhood.
Advertiser disclosure
Finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which Finder receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. Finder compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
How likely would you be to recommend Finder to a friend or colleague?
0
1
2
3
4
5
6
7
8
9
10
Very UnlikelyExtremely Likely
Required
Thank you for your feedback.
Our goal is to create the best possible product, and your thoughts, ideas and suggestions play a major role in helping us identify opportunities to improve.
